HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presence of a truncated M-type subunit and altered kinetic properties of 6-phosphofructo-1-kinase isozymes in the brain of a dog affected by glycogen storage disease type VII.

Abstract
6-Phosphofructo-1-kinase (PFK) activity in the brain of a dog affected by glycogen storage disease type VII was only 31% of the PFK activity in the normal dog brain. PFK in the normal dog brain was composed of L-type, M-type and C-type subunits with apparent molecular weights of 78,000, 86,000, and 88,000, respectively, and subunit proportions (L:M:C) of 27:49:24. PFK in the affected dog brain was composed of nearly equal levels of the normal L-type and C-type subunits, but a normal M-type subunit was not detected. Using antidog muscle PFK IgG, immunoblots of gels containing partially purified PFK from the affected dog brain revealed a small amount of immunoreactive protein with an apparent molecular weight of 84,000, suggesting the presence of a truncated M-type subunit. Kinetic studies indicated that the PFK isozymes in the affected dog brain exhibited significantly different kinetic regulatory properties when compared to the PFK isozyme pool in the normal dog brain.
AuthorsY Mhaskar, U Giger, G A Dunaway
JournalEnzyme (Enzyme) Vol. 45 Issue 3 Pg. 137-44 ( 1991) ISSN: 0013-9432 [Print] Switzerland
PMID1840037 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fructosediphosphates
  • Fructosephosphates
  • Isoenzymes
  • fructose-6-phosphate
  • fructose 2,6-diphosphate
  • Adenosine Triphosphate
  • Phosphofructokinase-1
Topics
  • Adenosine Triphosphate (pharmacology)
  • Animals
  • Brain (enzymology)
  • Dogs
  • Fructosediphosphates (pharmacology)
  • Fructosephosphates (pharmacology)
  • Glycogen Storage Disease Type VII (enzymology)
  • Isoenzymes
  • Kinetics
  • Phosphofructokinase-1 (chemistry, drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: